Anna Ressa

Pepscope BV is a company based in Utrecht, Netherlands that develops and provides advanced customer-focused protein analysis services and products. The Dutch company aims to make kinase inhibitors better therapeutics by providing unique insights into their functioning through quantitative profiling of the kinome in cells and tissues. Pepscope offers a unique, targeted mass-spectrometry-based, multiplexed, endogenous kinase activity profiling technology for clinical samples. Recently, Pepscope announced a 4.3-million-euro funding round to further develop and commercialize their lead product QuantaKinome™, which provides direct insights into the activities of hundreds of protein kinases simultaneously inside the cells of diseased tissues. Pepscope offers QuantaKinome™ to the pharmaceutical industry and academic researchers to improve the discovery and development of drugs. The company was founded by Jos Joore, Hans Brouwer, and Anna Ressa, with Anna Ressa serving as the CEO since incorporation.